Back
NewtekOne, Inc. 10K Form
Sell
50
NEWT
NewtekOne, Inc.
Last Price:
$11.27
Seasonality Move:
5.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | NEWT/NewtekOne, Inc. Quarterly |
| 2020-05-11 | 10Q | NEWT/NewtekOne, Inc. Quarterly |
| 2020-03-16 | 10K | NEWT/NewtekOne, Inc. Annual |
| 2019-11-12 | 10Q | NEWT/NewtekOne, Inc. Quarterly |
| 2019-08-09 | 10Q | NEWT/NewtekOne, Inc. Quarterly |
| 2019-05-03 | 10Q | NEWT/NewtekOne, Inc. Quarterly |
Receive NEWT News And Ratings
See the #1 stock for the next 7 days that we like better than NEWT
NEWT Financial Statistics
Sales & Book Value
| Annual Sales: | $333.5M |
|---|---|
| Cash Flow: | $7.6M |
| Price / Cash Flow: | 8.73 |
| Annual Sales: | $11.72 |
| Price / Book: | 0.96 |
Profitability
| EPS (TTM): | 2.22070 |
|---|---|
| Net Income (TTM): | $59.3M |
| Gross Margin: | $257.1M |
| Return on Equity: | 18.77% |
| Return on Assets: | 2.85% |
NewtekOne, Inc. Earnings Forecast
Key NewtekOne, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for NEWT is 77.10%.
-
The Selling, General & Administrative Expenses for NEWT have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 103.09% of Operating Income.
-
The Net Earning history of NEWT is 15.25% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
NewtekOne, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Financial Services |
| Sector: | Financials |
| Current Symbol: | NEWT |
| CUSIP: | 652526 |
| Website: | newtekone.com |
Debt
| Debt-to-Equity Ratio: | 4.99 |
|---|---|
| Current Ratio: | 2.78 |
| Quick Ratio: | 2.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.76 |
|---|---|
| Forward P/E Ratio: | 4.9 |
NEWT Technical Analysis vs Fundamental Analysis
Sell
50
NewtekOne, Inc. (NEWT)
is a Sell
Is NewtekOne, Inc. a Buy or a Sell?
-
NewtekOne, Inc. stock is rated a SellThe current NewtekOne, Inc. [NEWT] share price is $11.27. The Score for NEWT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.